Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of cytosolic proteins in lysosomes that contributes to cellular quality control and becomes an additional source of amino acids when nutrients are scarce. A chaperone complex delivers CMA substrates to a receptor protein at the lysosomal membrane that assembles into multimeric translocation complexes. However, the mechanisms regulating this process remain, for the most part, unknown. In this work, we have identified two regulatory proteins, GFAP and EF1a, that mediate a previously unknown inhibitory effect of GTP on CMA. GFAP stabilizes the multimeric translocation complex against chaperone-mediated disassembly, whereas GTP-mediated release of EF1a from the lysosomal membrane promotes self-association of GFAP, disassembly of the CMA translocation complex, and the consequent decrease in CMA. The dynamic interactions of these two proteins at the lysosomal membrane unveil now a role for GTP as a negative regulator of CMA.
INTRODUCTION
The degradation of intracellular proteins in lysosomes, or autophagy, takes place in mammalian cells through different mechanisms, namely macroautophagy, microautophagy, and chaperone-mediated autophagy (CMA) (Mizushima et al., 2008) . Cargo proteins are segregated ''in bulk'' from the rest of cytoplasmic components by a limiting membrane that seals to form a double-membrane vesicle-in macroautophagy-or by invaginations in the surface of the lysosomal membrane that pinch off into the lysosomal lumen-in microautophagy (Mizushima et al., 2008) . In contrast, the selective pool of cytosolic proteins degraded by CMA is directly translocated across the lysosomal membrane (Cuervo, 2010; Dice, 2007) . CMA is activated as part of the cellular response to oxidative stress to target oxidized proteins to lysosomes without perturbing neighboring unaffected proteins (Kiffin et al., 2004) . Also, during prolonged starvation, the selectivity of CMA provides cells amino acids through selective degradation of expendable proteins. CMA has proven to be important for maintenance of cellular homeostasis, in the cellular response to different stressors (oxidative stress, nutritional stress, etc.), and in antigen presentation. Alterations of CMA have been linked to different human pathologies such as Parkinson's disease, the hypertrophy associated with the diabetic kidney, and several lysosomal storage disorders (Cuervo, 2010; Dice, 2007) .
CMA is active in almost all cells, although basal and inducible levels of CMA activity vary depending on the cell type and cellular conditions (Cuervo, 2010) . CMA takes place through relatively well-characterized steps. Cargo is first selected for CMA through the interaction of a cytosolic chaperone, the heat shock cognate member of the hsp70 family (hsc70), with a pentapeptide motif present in the amino acid sequence of all CMA substrates (biochemically related to the pentapeptide KFERQ). The hsc70/substrate protein complex is then targeted to the lysosomal membrane, where it interacts with the lysosome-associated membrane protein type 2A (LAMP-2A), one of the three splice variants of the single gene lamp2 (Cuervo and Dice, 1996) .
LAMP-2A and a lysosome resident variant of hsc70 (lys-hsc70) are the only components of the translocation complex identified so far (Cuervo, 2010; Dice, 2007) . We have recently shown that the CMA translocation complex is dynamic (Bandyopadhyay et al., 2008) . In fact, LAMP-2A undergoes cycles of rapid assembly/disassembly into a 700 kDa protein complex at the lysosomal membrane (Bandyopadhyay et al., 2008) . CMA substrates bind to LAMP-2A only in its monomeric form, and this binding drives LAMP-2A multimerization into the 700 kDa protein complex necessary to attain substrate translocation (Bandyopadhyay et al., 2008) . Two lysosomal membrane chaperones, lys-hsc70 and lys-hsp90, participate in the LAMP-2A dynamics at the lysosomal membrane. Lys-hsc70 induces disassembly of LAMP-2A from the 700 kDa complex once the substrate has crossed the membrane, and lys-hsp90 stabilizes LAMP-2A during its transition from monomeric to multimeric forms (Bandyopadhyay et al., 2008) .
Despite these recent findings on the LAMP-2A dynamics at the lysosomal membrane and their effect on CMA, the mechanisms regulating protein translocation across the lysosomal membrane via CMA are still poorly characterized. In this work, we have identified a LAMP-2A-interacting protein at the lysosomal membrane that regulates the transport of substrate proteins via CMA in a nucleotide-dependent manner, revealing a previously unknown role for GTP in the regulation of CMA. Our studies support the existence of a fine-tuned regulatory mechanism for substrate binding and translocation via CMA based on the assembly of LAMP-2A into a multimeric complex and on the stability of this translocation complex at the lysosomal membrane.
RESULTS

Identification of LAMP-2A-Interacting Proteins at the Lysosomal Membrane
To identify protein components that may associate with the CMA translocation complex to modulate substrate transport, we first analyzed proteins that interact with LAMP-2A at the lysosomal membrane preferentially when CMA is activated. We used lysosomes isolated from mouse fibroblasts stably expressing a previously described HA (hemagglutinin)-tagged form of LAMP-2A (Cuervo and Dice, 2000) , which allows retrieval of only this LAMP-2 variant by immunoprecipitation with an antibody against HA. We displaced endogenous substrates bound to LAMP-2A by incubation with an excess of ribonuclease A (RNase A), a CMA substrate, to enhance the probability of recovering CMA regulators rather than CMA substrates. Analysis of the proteins coimmunoprecipitated with similar amounts of HA-LAMP-2A from lysosomes of cells maintained in the presence (low CMA activity) or absence (high CMA activity) of serum revealed that more proteins copurified with LAMP-2A in lysosomes from cells maintained in serumdeprived conditions ( Figure 1A , middle). Immunoblot analysis of the coimmunoprecipitates confirmed that the band at about 70 kDa corresponded to hsc70 (data not shown). Tandem mass spectrometry analysis of the protein band at 50 kDa identified it as glial fibrillary acidic protein (GFAP), a cytoplasmic intermediate filament protein involved in the formation of the intracellular framework. Despite its name, GFAP has been identified in multiple cell types and tissues (Morini et al., 2005) . Immunofluorescence for GFAP in hepatocytes in culture (RALA cells) or in mouse fibroblasts (3T3 cells) revealed a reticular/punctate pattern for this protein, rather than the characteristic filamentous pattern of intermediate filaments ( Figure S1A available online) . In fact, costaining for vimentin, another intermediate filament protein, showed only partial colocalization of both proteins, as vimentin was mainly enriched in filamentous structures compatible with intermediate filaments ( Figure S1B ). Immunoblot of rat liver lysosomes with high activity for CMA (CMA+; enriched in hsc70) and lysosomes incompetent for CMA (CMAÀ; lacking hsc70 in their lumen) (Cuervo et al., 1997) revealed the preferential association of GFAP with CMA+ lysosomes ( Figure 1B ). Lysosomal GFAP was not mere contamination by intermediate filaments, as vimentin presented a rather different pattern of association to lysosomes (detected in both CMA+ and CMAÀ lysosomes but only under fed conditions) ( Figure 1B) . Although more GFAP interacted with LAMP-2A during CMA activation ( Figure 1A ), the total lysosomal content of GFAP did not change significantly upon CMA upregulation by starvation in rat liver ( Figure 1B ) or serum removal in cultured cells ( Figure 1C ). These results support that, whereas an almost constant fraction of intracellular GFAP resides in lysosomes, activation of CMA promotes the interaction of lysosomal GFAP with LAMP-2A.
To further characterize the association of GFAP with lysosomes and determine its topology in this compartment, we first separated the lysosomal membrane and matrix by hypotonic shock and high-speed centrifugation and found most of the lysosomal GFAP (about 85%) in the lysosomal membrane fraction (Figure 1D , top; hsp40 is used as an example of membraneassociated peripheral protein and hsp90 of protein present both in the membrane and lumenal fractions). Close to 80% of lysosomal GFAP was released from the lysosomal membrane by high salt or alkaline wash ( Figure 1E ; NaCl and Na 2 CO 3 released 72% ± 12% and 78% ± 13% of the membrane-associated GFAP, respectively). GFAP was accessible to degradation by exogenous proteases (trypsin shown in Figure 1F ), supporting its peripheral association with the cytosolic side of the lysosomal membrane. The resistance of the lumenal region of LAMP-1 to the protease treatment and the susceptibility of hsp40 were used as control ( Figure 1F) .
A percentage of LAMP-2A can be coimmunoprecipitated with GFAP from rat liver lysosomal membranes, and this interaction increases with starvation ( Figure 1G ). We confirmed that association of GFAP to the lysosomal membrane requires, at least in part, the presence of LAMP-2A because lysosomes lacking LAMP-2A (from mouse fibroblasts RNAi for LAMP-2A ) contained about 25% of the GFAP detected in lysosomes isolated from control mouse fibroblasts ( Figure 1H ).
Binding to LAMP-2A and the fact that GFAP bears in its sequence three KFERQ-like motifs makes it a putative CMA substrate. However, in contrast to the rapid degradation of CMA substrates in lysosomes (GAPDH is shown in Figure S1C ), GFAP remained stably associated with the lysosomal membrane. To directly analyze lysosomal uptake of GFAP by CMA, we used a well-established in vitro assay with isolated lysosomes. Although both GAPDH and GFAP bound to the lysosomal membrane in a concentration-dependent manner, uptake, which usually correlates well with binding, was only detectable for GAPDH ( Figure S1D ). Furthermore, lysosomal levels of GFAP remained unchanged in mice injected with leupeptin to inhibit lysosomal protein degradation, in contrast with the increase observed for bona fide CMA substrates such as IkBa ( Figure S1E , compare lanes 3 and 4). Despite the preferential association of GFAP with CMA+ lysosomes, our results do not support GFAP being a substrate for degradation via CMA, at least under normal conditions, which led us to investigate a possible functional role for GFAP in CMA.
GFAP Modulates CMA Activity in a GTP-Dependent Manner To further characterize the lysosomal association of GFAP, we used purified GFAP and first determined its oligomeric status before and after presenting it to lysosomes. Blue native electrophoresis (BNE) revealed that almost 95% of purified GFAP resolved as a monomer of $50 kDa ( Figure S2A ), and this was still the predominant form after incubation with lysosomes (Figure S2B ). At this concentration of lysosomes, only the exogenously added GFAP was readily detectable. However, upon prolonged exposure ( Figure S2B , middle) or loading higher amounts of lysosomes ( Figure S2B , right), we detected the endogenous lysosome-associated GFAP at 100, 250, and 700 kDa (Figure S2B, right) . We did not observe very high-order multimerization of GFAP (filaments) in the conditions of our assay, although purified GFAP self-assembled when incubated with the adequate buffer and in the absence of lysosomes ( Figure S2A , lane 2, and Figure S2C , lanes 3 and 4 > 900 kDa). Purified GFAP efficiently bound to isolated lysosomes in a LAMP-2A-dependent manner, as binding was markedly reduced in lysosomes lacking LAMP-2A ( Figure S2D ).
Using the purified GFAP, we further characterized its association to lysosomes. Rho-GTP is known to regulate GFAP in intermediate filaments (Borá n and García, 2007) , prompting us to analyze the effect of different nucleotides on lysosomal GFAP. As shown in Figure 2A , ATP or its nonhydrolyzable analog (g-ATP) did not significantly change the amount of GFAP that binds to the lysosomal membrane, whereas both GTP and its nonhydrolyzable analog (g-GTP) markedly enhanced binding of GFAP to lysosomes. At the concentrations used in this study, none of the nucleotides affected the stability of the lysosomal membrane ( Figure S2E ). BNE revealed that GTP resulted in a shift of a percentage of the exogenously added GFAP to the 100 kDa region ( Figure S2B ).
We found that similar amounts of GTP reduced CMA activity. The amount of radiolabeled cytosolic proteins taken up and degraded by isolated intact lysosomes in the presence of GTP or g-GTP was significantly reduced when compared with untreated samples ( Figure 2B ). This effect was no longer evident when the lysosomal membrane was previously disrupted, discarding a possible effect of GTP on the proteases ( Figure 2B ). The inhibitory effect of GTP on CMA was dose dependent and reached a plateau of 57% inhibition at concentrations of 5 mM ( Figure 2C ). Incubation of intact lysosomes with increasing concentrations of GFAP in the absence of GTP increased substrate uptake and degradation, but only by CMA+ lysosomes ( Figure 2D ). Addition of GTP neutralized this stimulatory effect of GFAP on CMA at all concentrations tested ( Figure 2D ). Lysosomal binding of GFAP increased proportionally to the amount added in the media, both in the presence and absence of GTP, but was saturable in both cases ( Figure 2E ). In contrast, binding of GFAP to CMAÀ lysosomes was markedly lower than for CMA+ lysosomes, not saturable (likely due to nonselective binding), and insensitive to GTP ( Figure 2F ) even upon addition of hsc70 ( Figure 2G ). In summary, our results support the existence of unique components/properties at the membrane of CMA+ lysosomes that differently modulate GFAP binding and that binding of GFAP to the lysosomal membrane has different consequences on CMA depending on whether it occurs in the presence or absence of GTP.
To determine the CMA step(s) modulated by GTP and GFAP, we incubated lysosomes with substrate proteins at low temperatures, which allows for the dissociation of substrate binding from uptake ( Figure 2H ). Binding of two well-characterized CMA substrate proteins, RNase A (left) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (right), was significantly reduced in the presence of GTP, accounting for the reduced uptake observed with the previous assay. The small but consistent stimulatory effect of GFAP on the levels of substrate binding was also neutralized in the presence of GTP ( Figure 2H ).
Lentivirus-mediated RNAi against GFAP in rat liver hepatocytes ( Figure 3A in the formation of intermediate filaments in hepatocytes ( Figure S3A ), but eliminated the 50 kDa band in lysosomes, confirming that the protein detected in lysosomes was indeed GFAP ( Figure 3A , bottom). Contrary to our initial prediction, based on the stimulatory effect of GFAP in vitro, we found increased degradation of radiolabeled substrate proteins by lysosomes in the knockdown cells ( Figure 3B) . A similar increase (about 20%) was observed in the binding of substrate protein ( Figure 3C ) and in the proteolysis of a pool of radiolabeled cytosolic proteins (data not shown) by intact lysosomes isolated from livers of GFAP knockout mice when compared to lysosomes from wildtype littermates. In agreement with their higher CMA activity, lysosomes from GFAP knockout mice also displayed higher levels of both LAMP-2A and hsc70 ( Figure 3D ). This observation suggests a compensatory mechanism only detected in cells knocked out for GFAP (chronic), but not in knockdown (acute) cells until they were maintained in culture for several weeks ( Figure S3B ). Therefore, all of the functional experiments were performed at 2 weeks of knockdown, when LAMP-2A compensation is still not evident (i.e., see LAMP-2A in Figure 3E ). Changes in proteolysis were mainly due to increased substrate binding to lysosomes from knockdown cells (RNase A shown in Figure 3E ). Of interest, the inhibitory effect of GTP on substrate binding was significantly lower in the absence of GFAP (Figure 3E ), supporting that GTP inhibits CMA, at least partially, through its effect on GFAP. Similar effects for GFAP and GTP were observed when we measured protein degradation in intact cells. Although cells knocked down for GFAP display only slightly higher rates of degradation of long half-life proteins compared to control cells ( Figure 3F , top), these differences become significant when the percentage of degradation contributed by the lysosomal system (sensitive to inhibition by ammonium chloride) is determined ( Figure 3F, bottom) . Depletion of intracellular levels of GTP with mycophenolic acid (MPA), a potent selective inhibitor of GTP synthesis shown to reduce intracellular levels of this nucleotide by up to 80% (Nguyen et al., 1983) , led to a significant increase in rates of protein degradation ( Figure 3G ). This effect can be completely eliminated when lysosomal proteolysis is inhibited ( Figure S3C ), supporting its lysosomal origin. Although different types of autophagy contribute to lysosomal degradation, the fact that depletion of GTP did not have any effect on the rates of lysosomal degradation in cells incompetent for CMA (knocked down for LAMP-2A; Figure S3D ) strongly supports that GTP was mainly acting on CMA. As further support that the inhibitory effect of GTP is exerted, at least in part, through GFAP, the increase in lysosomal protein degradation observed upon GTP depletion in control cells was no longer evident in GFAP knockdown cells ( Figure 3G ). In fact, depletion of GTP abolished their enhanced lysosomal proteolysis.
To gain further insight on the physiological relevance of the GTP-dependent regulation of CMA by GFAP, we analyzed the response to oxidative stress of control and GFAP knockdown cells. CMA is upregulated during mild oxidative stress (Kiffin et al., 2004) , and failure to activate CMA under these conditions compromises cell viability . Depletion of GTP increased resistance of cells to the pro-oxidant paraquat, but only in CMA-competent cells ( Figure 3H ). In support of the net positive outcome on CMA upon knocking down GFAP, GFAP-deficient cells displayed higher resistance ( Figure 3I ) and lower levels of oxidized proteins ( Figure 3J ) after exposure to the pro-oxidant.
Our results both in vitro and in intact cultured cells support that GFAP contributes to modulate CMA in response to both starvation and oxidative stress, two well-characterized CMA activators, and that the effect of GFAP on CMA is regulated by GTP.
GTP and GFAP Modify the Dynamics of LAMP-2A at the Lysosomal Membrane To explore the mechanism by which GFAP and GTP modulate CMA activity, we first analyzed the interaction of GFAP with different components of the CMA translocation machinery. In addition to LAMP-2A, a fraction of GFAP interacted with hsc70 at the lysosomal membrane. Although GFAP failed to pull down hsc70 from the lysosomal membrane ( Figure 4A) , part of the lysosome-associated GFAP was recovered in lysosomal hsc70 pull-downs ( Figure 4B ). Hsc70 and LAMP-2A participate in substrate targeting and binding to the membrane; however, the fact that GFAP did not interact with entering substrates (GAPDH shown in Figure S4A ) suggested that GFAP may not be involved in these CMA steps. The other functional interaction between hsc70 and LAMP-2A pertains to the assembly/ disassembly of LAMP-2A in a 700 kDa multimeric complex at the lysosomal membrane required for substrate translocation (Bandyopadhyay et al., 2008) . We analyzed the effect of GTP and GFAP on the formation of this translocation complex using BNE. Treatment with GFAP increased the amount of LAMP-2A present in the high molecular weight complex ( Figure 4C ), whereas GTP reduced the amount of LAMP-2A in this complex even when lysosomes were supplemented with exogenous GFAP ( Figure 4C ). Inversely, lysosomes isolated from GTPdepleted cells showed a higher percentage of LAMP-2A in the multimeric complex, but this effect was no longer observed in cells knocked down for GFAP ( Figure 4D ), supporting that the regulatory effect of GTP on CMA is mediated through GFAP. Of interest, lysosomes from cells knocked down for GFAP were still able to form the 700 kDa translocation complex ( Figure 4D ), suggesting that, although GFAP enhances the amount of LAMP-2A present in this complex, it is not required for its assembly, but it may be important to maintain its stability. We have previously demonstrated a disassembly function for hsc70 over this complex (Bandyopadhyay et al., 2008) and have now found that hsc70-mediated disassembly of the LAMP-2A complex was, to a large extent, neutralized in the presence of GFAP ( Figure 4E ).
The changes in LAMP-2A multimerization are in agreement with the differences that we observed in the association of LAMP-2A to lipid microdomains at the lysosomal membrane. A percentage of LAMP-2A associates in a monomeric state with specific lipid microdomains at the lysosomal membrane, but upon CMA activation, LAMP-2A is excluded from these regions and organizes into multimeric complexes . We have now found higher levels of LAMP-2A in lipid microdomains in the presence of GTP, whereas GFAP reduced the levels of LAMP-2A in these regions ( Figure 4F ). As observed for substrate binding and LAMP-2A multimerization, combined addition of GFAP and GTP neutralized the effect of GFAP alone ( Figure 4F ). GFAP did not mobilize to the microdomains under these conditions ( Figure S4B ). We confirmed the GTP-induced mobilization of LAMP-2A toward the microdomains by measuring the degradation rates of LAMP-2A in lysosomes supplemented with Ca +2 and incubated in the absence of protease inhibitors. We have previously shown that LAMP-2A is degraded in a Ca +2 -dependent manner in the microdomains . Lysosomes treated with GTP displayed higher rates of LAMP-2A degradation than control lysosomes ( Figure S4C ). Our studies support that the regulatory effect of GFAP and GTP on CMA occurs at the level of the organization of the translocation complex at the lysosomal membrane.
A GTP-Binding Protein at the Lysosomal Membrane
Modulates CMA Activity To elucidate how the GTP-dependent effect of GFAP on CMA is modulated, we first analyzed changes in the lysosome-associated GFAP. Immunoblot for GFAP phosphorylation, which modulates GFAP self-assembly and stability (Noetzel, 1990; Takemura et al., 2002) , revealed that about 1.5% of cellular P GFAP was recovered in CMA+ lysosomes, versus the 0.5%-1% of total GFAP, or 0.5% of hsc70 (a well-established CMA regulator) ( Figure S5B ). The total lysosomal content of P GFAP did not change when CMA was activated by prolonged starvation ( Figure S5A ) or mild oxidative stress ( Figure S5C ). Although phosphorylation of GFAP is not required for lysosomal binding (the exogenously added GFAP was not phosphorylated), the endogenous GFAP in the 100 kDa region was phosphorylated ( Figure S5D ). GFAP phosphorylation may contribute to stabilize GFAP once at the lysosomal membrane and prevent further self-assembly in this compartment (compare with the high-order multimerization of GFAP in a purified intermediate filament enriched fraction; Figure S5F) . The interdependent effect of GTP and GFAP on CMA activity, the GTP-dependent enhanced binding of GFAP to the lysosomal membrane, and the inability of GFAP to directly bind GTP led us to hypothesize the possible participation of a GTP-binding protein in the regulatory effect of GFAP on CMA. GTP affinity chromatography of solubilized membranes from CMA+ lysosomes revealed a subset of lysosomal proteins that bound to the immobilized GTP ( Figure 5A ). To determine which of the GTP-binding proteins could be functionally related to GFAP and consequently contribute to its GTPdependent binding to the lysosomal membrane, we subjected the eluted lysosomal GTP-binding proteins to panning with GFAP ( Figure 5A, right) . Out of the three proteins able to bind both GTP and GFAP, we obtained positive identification by MS/MS of the one of $50 kDa to be elongation factor 1 alpha (EF1a).
A portion of intracellular EF1a colocalized with LAMP-1 or LAMP-2A ( Figure 5B ) by immunofluorescence in fibroblasts in culture. Immunoblot for EF1a in lysosomes isolated from rat liver confirmed that EF1a was more abundant in CMA+ lysosomes ( Figure 5C ). Topological analysis similar to that described for GFAP revealed that lysosomal EF1a is preferentially found in the membrane fraction ( Figure 5D ). High salt concentration washes and alkali extraction removed about 65% + 15% and 87% + 8% of the lysosomal EF1a, respectively ( Figure 5E ). Susceptibility of EF1a to treatment with an exogenous protease (trypsin) confirmed its association with the cytosolic side of the lysosome membrane ( Figure 5F ). GFAP ( Figure 6A , top), but not LAMP-2A ( Figure 6A , bottom), can be coimmunoprecipitated with EF1a from lysosomes, supporting that, contrary to GFAP, EF1a did not interact directly with LAMP-2A. Endogenous GFAP and EF1a were both detected in the 100 KDa complex by BNE ( Figure 6B ), but only Values are all mean + SE. *p < 0.05.
Molecular Cell
Modulators of Chaperone-Mediated Autophagy GFAP was detected in the 700 kDa region. Immunoblot for P GFAP revealed that most of the GFAP in the 100 kDa was phosphorylated. Exogenous GFAP (not detected by the P GFAP antibody), when incubated with lysosomes, did not change levels of P GFAP in the 100 kDa complex but markedly reduced levels of EF1a in this complex. Because both proteins have a molecular weight of 50 kDa, it is difficult to differentiate homodimers from heterodimers of both proteins. However, different independent evidence supports that GFAP and EF1a form heterodimers at the membrane, which are disrupted in the presence of GTP. First, incubation of lysosomes with exogenous GFAP and GTP increased the amount of GFAP in the 100 kDa complex while markedly reducing the amount of EF1a present in this complex ( Figure 6B ). In addition, the amount of GFAP coimmunoprecipitated with EF1a also decreased upon addition of GTP ( Figure 6C ; 47.2% decrease). Lastly, incubation of lysosomes with exogenous GFAP in the presence of GTP significantly reduced levels of endogenous EF1a in lysosomes ( Figure 6D ). This reduction was not due to EF1a proteolysis because all of the experiments were performed in the presence of protease inhibitors, suggesting instead that the decrease in lysosomal levels of EF1a originates from its release from the lysosomal membrane. Conversely, we found markedly higher levels of EF1a in lysosomes isolated from GTP-depleted cells ( Figure 6E) .
Our results support the presence of at least two different pools of GFAP at the lysosomal membrane because part of GFAP was associated to LAMP-2A and part to EF1a, but LAMP-2A and EF1a were never recovered in the same complex. In fact, blockage of the cytosolic tail of LAMP-2A at the lysosomal membrane by preincubation with antibodies against this tail reduced binding of GFAP to the lysosomal membrane (Figure 6F ) but did not affect its GTP-dependent binding ( Figure 6F ; a 3.5-fold increase in membrane levels of GFAP was still evident even when LAMP-2A was blocked). Preincubation of lysosomes with antibodies against LAMP-2B or hsc70 did not reduce GFAP binding, supporting the selectivity for LAMP-2A binding ( Figure 6F ). We further confirmed the existence of this LAMP-2A-independent binding of GFAP to the lysosomal membrane in the presence of GTP using cells knocked down for LAMP-2A ( Figure 6G ). To further investigate the requirements for EF1a in this process, we first attempted to knock down EF1a, but probably because of the many other functions reported for this protein, cells presented marked alterations in the lysosomal compartment (leaky lysosomes and severe reduction of LAMPs; data not shown) that prevented us from analyzing CMA activity in them. As an alternative approach, we used antibodies to block lysosome-associated EF1a and found that its blockage preferentially reduced the GTP-dependent binding of GFAP ( Figure 6H ), supporting that the additional binding of GFAP to the lysosomal membrane in the presence of GTP was attained by exchange/release of the membrane-associated EF1a. Of interest, binding of EF1a to the lysosomal membrane required GFAP. In fact, levels of EF1a were markedly reduced in lysosomes isolated form cells knocked down for GFAP ( Figure 6I ), although total cellular levels of EF1a were higher in those cells ( Figure S6 ).
Lysosomal levels of EF1a, rather than total intracellular levels of this protein, contribute to modulate CMA activity. We did not observe transcriptional activation of EF1a ( Figure 7A ) or an increase in total cellular EF1a ( Figures 7B and 7C ) in two conditions known to activate CMA-starvation and mild oxidative stress. However, immunofluorescence of cultured cells (Figure 7D) and immunoblot of isolated liver lysosomes ( Figure 7E ) revealed a significant increase in association of EF1a to lysosomes in these conditions. Blockage of lysosomal proteolysis did not affect cellular levels of EF1a discarding degradation in this compartment ( Figure S6B ). Bidimensional electrophoretic analysis revealed that only particular isoforms of EF1a associate to lysosomes ( Figure 7F ) and that lysosomal EF1a, but not the cytosolic form, undergoes charge changes during CMA activation ( Figure 7F ). Our results support that the effect of EF1a on CMA is likely exerted by a particular isoform of this protein.
Overall, our results support that EF1a binds to the lysosomal membrane through the pool of GFAP not interacting with LAMP-2A (see model in Figure S7 ); upon addition of GTP, EF1a is released from this GFAP, allowing binding of other GFAP molecules (likely those previously interacting with LAMP-2A).
DISCUSSION
This study provides evidence of the complexity and fine-tuning of the regulation of the degradation of cytosolic proteins via CMA. We have shown that cytosolic levels of GTP exert a previously unknown regulatory effect on CMA through the intricate dynamics of two proteins, GFAP and EF1a, with the CMA receptor protein LAMP-2A, at the lysosomal membrane ( Figure S7 ). GFAP binding to LAMP-2A stabilizes the LAMP-2A multimeric complex by preventing the disassembling effect of hsc70. In the presence of GTP, EF1a is released from the GFAP at the lysosomal membrane, allowing its self-assembly with the GFAP molecules released from LAMP-2A, which is then mobilized to the lipid microdomains for degradation.
The presence of two different pools of GFAP at the lysosomal membrane provides an explanation for the initial apparent dichotomy between our results in isolated lysosomes, where addition of GFAP enhanced CMA activity, and in cultured cells lacking GFAP, where CMA activity was also enhanced. The pool of GFAP bound to LAMP-2A prevents the disassembly of the CMA translocation complex, having a stimulatory effect on CMA. In contrast, the portion of GFAP at the lysosomal membrane that is not bound to LAMP-2A contributes to the GTP inhibitory effect of CMA by binding the GFAP previously associated to the LAMP-2A complexes. The amount of EF1a at the lysosomal membrane may be the limiting factor that prevents binding of GFAP to the LAMP-2A unbound fraction in the in vitro system. In cultured cells, knockdown of GFAP decreases both pools, the LAMP-2A bound and unbound. The enhanced CMA activity detected in these cells suggests that the net outcome of GFAP activity at the lysosomal membrane in the presence of normal cytosolic levels of GTP is mainly inhibitory and also reinforces that GFAP is not required for formation of the CMA translocation complex; rather, it prevents or slows down its disassembly by hsc70. Regulation of CMA by GFAP could reach an additional level of complexity through the degradation of GFAP by this pathway. Although our results do not support GFAP being a CMA substrate, the existence of three KFERQ-like motifs in its amino acid sequence could allow GFAP to undergo CMA in yet to be determined conditions.
An intriguing aspect of our findings is that the GTP inhibitory effect was still observed even in the absence of exogenously added GFAP in vitro. This finding suggests that GTP modifies or redistributes the GFAP already present at the lysosomal membrane in order to attain the inhibitory effect. We have found that this redistribution is associated with the release of EF1a, a GTP-binding protein, from the lysosomal membrane. Although further investigation is required, it is possible that, upon addition of GTP, release of EF1a from the LAMP-2A unbound GFAP results in a conformational change in this GFAP that enhances its affinity for other GFAP molecules (those bound to LAMP-2A) and favors its self-assembly at the lysosomal membrane.
Furthermore, because phosphorylation of lysosomal GFAP seems to be restricted to the protein present in the 100 kDa region, but not interacting with the LAMP-2A complex, it is possible that changes in phosphorylation of GFAP may modulate its distribution between these two pools.
The GTP-dependent effect of GFAP on LAMP-2A dynamics provides a regulatory mechanism for the previously described association of LAMP-2A to lysosomal lipid microdomains . Movement of LAMP-2A toward these regions decreases the number of LAMP-2A multimeric complexes and reduces CMA activity . However, recruitment of LAMP-2A to microdomains is not only a mechanism for CMA downregulation, but also serves to ensure the normal turnover of LAMP-2A. In fact, we have recently reported that alterations in the ability of LAMP-2A to reach the lysosomal microdomains, such as those observed in aging, result in destabilization of this protein and its abnormal random degradation in the lysosomal compartment (Cuervo, 2010; Dice, 2007) . From this perspective, the GTP-modulated effect of GFAP may contribute to normal homeostasis of LAMP-2A at the lysosomal membrane by favoring its association to microdomains. The dynamic balance between the LAMP-2A bound and unbound pools of GFAP at the lysosomal membrane becomes in this way an important modulator of the distribution of LAMP-2A between the CMA translocation complex and the regions responsible for its turnover. Neither GFAP nor EF1a have been described before as lysosome-associated proteins, although localization of GFAP in compartments other than intermediate filaments has been reported (Morini et al., 2005) . Here, we have found association of GFAP with lysosomes in hepatocytes and mouse and rat fibroblasts, cells in which only a small percentage of GFAP seems to associate into intermediate filaments. To the best of our knowledge, the only connection between GFAP and the lysosomal system reported so far is the upregulation of macroautophagy in astrocytes expressing mutant forms of GFAP known to produce Alexander disease (Tang et al., 2008) . Blockage of CMA has been shown to upregulate macroautophagy . Consequently, it is possible that the high levels of GFAP in Alexander-affected cells result in CMA inhibition, and this contributes, at least in part, to the observed increase in macroautophagy activity in these cells.
The presence of a portion of cellular EF1a associated to lysosomes comes as less of a surprise because multiple functions and diverse cellular locations have already been described for this protein. A role in protein translation (Dreher et al., 1999) , cytoskeleton rearrangement, and protein deubiquitination and chaperoning (Xia et al., 2008) has been proposed for EF1a. However, it is still not clear how the participation of EF1a in these different functions is modulated. Recently, two competent EF1a genes, which are differentially expressed, have been identified in mammals. Although the significance of the two different protein products (92% identical) remains elusive, it is possible that the different isoforms have different intracellular locations/functions and that the lysosome-associated form of EF1a could correspond to only one of these variants. In fact, our results support preferential association of particular EF1a isoforms to lysosomes and further changes with CMA activation. The electrophoretic differences observed for the lysosomal EF1a may originate from alternative splicing or posttranslational modifications. The absence of transcriptional changes in EF1a during CMA activation makes us favor the second possibility. EF1a has been shown to be phosphorylated (Izawa et al., 2000) , methylated, and to covalently bind ethanolamine (Coppard et al., 1983) . Whether changes in these posttranslational modifications could modulate its interaction with GFAP at the lysosomal membrane requires further investigation.
GTP has been connected to autophagy, as it modulates some of the Rab proteins (Rab7, 32, and 33) known to participate in macroautophagy. Our findings reveal a connection between GTP and the degradation of cytosolic proteins by CMA through its effect on EF1a and GFAP. These components could represent possible new targets for interventions aimed at upregulating CMA activity in conditions in which declined CMA activity has been reported, such as aging or familial forms of Parkinson's disease (Cuervo, 2010) .
EXPERIMENTAL PROCEDURES Animals and Cells
We used adult male Wistar rats (200-250 g). Mouse fibroblasts (NIH 3T3) were from the American Type Culture Collection, and clones stably RNAi for LAMP-2A were described previously . The rat hepatocyte line RALA255-10G was cultured as described (Bandyopadhyay et al., 2008) .
Chemicals
Sources of antibodies and reagents are described in the Supplemental Information.
Isolation of Subcellular Fractions
Lysosomes from rat liver and cultured cells were isolated from a light mitochondrial-lysosomal fraction by centrifugation through a discontinuous metrizamide (Cuervo et al., 1997) or metrizamide/percoll discontinuous density gradient (Storrie and Madden, 1990) , respectively. Only preparations with more than 95% intact lysosomes were used. Lysosomal matrices and membranes were separated by centrifugation after hypotonic shock (Storrie and Madden, 1990) .
Measurement of CMA Activity CMA was measured in vitro as the uptake and degradation of substrate proteins by isolated lysosomes and, in cells in culture, as the rates of degradation of long-lived protein sensitive to ammonium chloride and insensitive to 3-methyladenine, as described before (Kaushik and Cuervo, 2009 ) and detailed in Supplemental Information.
Protein Coimmunoprecipitation
Coimmunoprecipitation was done from lysosomal membranes solubilized in 25 mM Tris (pH 7.2), 150 mM NaCl, 5 mM MgCl 2 , 0.5% NP-40, 1 mM DTT, 5% glycerol, and protease inhibitors (Co-IP buffer) for 15 min on ice and then centrifuged for 15 min at 16,000 3 g.
GTP Affinity Chromatography
Guanosine-5 0 triphosphate agarose was used for GTP affinity chromatography. Lysosomal membranes solubilized as above were passed through the GTP affinity column, and the bound fraction was eluted using an excess of GTP.
Immunofluorescence Staining
Cells grown on coverslips until confluent and kept in the presence or absence of serum for 20 hr were fixed in methanol at À20 C, blocked (1% BSA, 2% newborn calf serum, and 0.01% Triton X-100), and then incubated with the primary and corresponding fluorescent-conjugated secondary antibodies as described . Images were acquired with an Axiovert 200 fluorescence microscope (Carl Zeiss) and subjected to deconvolution with the manufacturer's software. Colocalization was determined using MetaMorph (Universal Imaging). Confocal images were acquired using a Leica SP5II AOBS laser-scanning confocal microscope. Colocalization was determined using ImageJ (JACOP plug-in).
RNAi shRNAs against GFAP were from the Sigma Mission Library. Sequence is described in the Supplemental Information.
Statistical Analysis
The statistical significance of the difference between experimental groups was determined by two-tailed unpaired Student's t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures and seven figures and can be found with this article online at doi:10.1016/ j.molcel.2010.08.004.
